National Cancer Institute   U.S. National Institutes of Health | www.cancer.gov
US National Institute of Health www.cancer.gov
BCSC
Breast Cancer Surveillance Consortium: Working together to advance breast cancer research
 
Home   |   Data & Statistics   |   Collaborations   |   Work with Us   |   Publications   |   About   |   Links

Cancers by Indication for Examination for 401,572 Diagnostic Mammography Examinations from 2002 - 2006 --- based on BCSC data as of 2009

You are viewing the 2009 collection of this data. Data from other times are also available:
Work-Up of Abnormal Screening Examination
N=143,916
Short-Interval Follow-Up
N=86,633
Evaluation of Breast Problem/No Lump or Lump Unknown
N=112,068
Evaluation of Breast Problem/Palpable Lump
N=58,955
All Diagnostic Examinations
N=401,572
All Cancers* 5,282 737 2,125 3,482 11,626
Cancer diagnosis rate (per 1000) 36.7 8.5 19.0 59.1 29.0
Cancer histology
DCIS 1,436 (27.2) 227 (30.8) 313 (14.7) 162 (4.7) 2,138 (18.4)
All invasive 3,846 (72.8) 510 (69.2) 1,812 (85.3) 3,320 (95.3) 9,488 (81.6)
Invasive cancer size
Invasive, 1-5 mm 445 (12.5) 84 (18.3) 110 (6.5) 55 (1.8) 694 (7.9)
Invasive, 6-10 mm 1,064 (30.0) 133 (29.0) 247 (14.7) 231 (7.6) 1,675 (19.2)
Invasive, 11-15 mm 946 (26.6) 121 (26.4) 329 (19.6) 546 (18.0) 1,942 (22.2)
Invasive, 16-20 mm 448 (12.6) 44 (9.6) 298 (17.7) 526 (17.3) 1,316 (15.1)
Invasive, >20 mm 647 (18.2) 77 (16.8) 697 (41.5) 1,683 (55.3) 3,104 (35.6)
Invasive, size unknown 296 51 131 279 757
Invasive, mean size (mm) 15.9 15.6 24.2 27.2 21.5
Invasive, median size (mm) 12 12 19 22 16
Minimal cancer§ 2,945 (59.1) 444 (64.7) 670 (33.6) 448 (14.0) 4,507 (41.5)
Axillary lymph node status (invasive cancers)||
Node negative 2,967 (80.6) 390 (82.5) 1,135 (64.5) 1,817 (56.5) 6,309 (69.1)
Node positive 716 (19.4) 83 (17.5) 625 (35.5) 1,397 (43.5) 2,821 (30.9)
Nodal status unknown 163 37 52 106 358
Cancer stage#
Stage 0 1,436 (28.9) 227 (33.4) 313 (16.0) 162 (5.1) 2,138 (19.9)
Stage I 2,467 (49.7) 328 (48.2) 762 (38.9) 967 (30.7) 4,524 (42.1)
Stage II 893 (18.0) 93 (13.7) 659 (33.6) 1,492 (47.4) 3,137 (29.2)
Stage III 144 (2.9) 29 (4.3) 153 (7.8) 382 (12.1) 708 (6.6)
Stage IV 27 (0.5) 3 (0.4) 74 (3.8) 147 (4.7) 251 (2.3)
Stage unknown 315 57 164 332 868
Cancer grade^
Grade 1 1,207 (26.3) 149 (24.3) 400 (21.6) 436 (14.1) 2,192 (21.6)
Grade 2 1,945 (42.3) 270 (44.1) 751 (40.6) 1,162 (37.6) 4,128 (40.7)
Grade 3 1,225 (26.7) 155 (25.3) 619 (33.4) 1,373 (44.5) 3,372 (33.2)
Grade 4 218 (4.7) 38 (6.2) 82 (4.4) 116 (3.8) 454 (4.5)
Grade unknown 687 125 273 395 1,480

Notes

Numbers are frequencies unless otherwise indicated.

* Cancers = The number of cancers diagnosed within 1 year following an examination with an abnormal final interpretation. (BI-RADS category 4 or 5 -- categories 0 or 3 with a recommendation for biopsy were recoded as 4).

Numbers in parentheses are percentages of all cancers.

Numbers in parentheses are percentages of invasive cancers of known size.

§ Minimal cancer = DCIS or invasive cancer <= 10 mm; numbers in parentheses are percentages of DCIS + invasive cancer of known size.

|| Numbers in parentheses are percentages of invasive cancers of known nodal status.

# Numbers in parentheses are percentages of DCIS + invasive cancers of known stage.

^ Numbers in parentheses are percentages of DCIS + invasive cancers of known grade.

Table numbers last updated June 28, 2010. The following source must be cited when reproducing this table: NCI-funded Breast Cancer Surveillance Consortium co-operative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). Downloaded xx/xx/xxxx from the Breast Cancer Surveillance Consortium Web site - http://breastscreening.cancer.gov/data/benchmarks/diagnostic/2009/table4.html

[Return to Performance Benchmarks for Diagnostic Mammography]


National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences